# DBV Technologies (stock symbol: DBVT) Logo in transparent PNG and SVG formats

## DBV Technologies Logo large

### DBV Technologies Logo large Download PNG (95.25 KB)

![DBV Technologies Logo large Download PNG (95.25 KB)](/img/orig/DBVT_BIG-32a513b8.png)

### DBV Technologies Logo large Download SVG (7.11 KB)

![DBV Technologies Logo large Download SVG (7.11 KB)](/img/orig/DBVT_BIG-f6c6285c.svg)

## DBV Technologies Logo icon format

### DBV Technologies Logo icon format Download PNG (59.27 KB)

![DBV Technologies Logo icon format Download PNG (59.27 KB)](/img/orig/DBVT-e413925f.png)

### DBV Technologies Logo icon format Download SVG (1.43 KB)

![DBV Technologies Logo icon format Download SVG (1.43 KB)](/img/orig/DBVT-4327ecca.svg)

## DBV Technologies Logo large for dark backgrounds

### DBV Technologies Logo large for dark backgrounds Download PNG (56.38 KB)

![DBV Technologies Logo large for dark backgrounds Download PNG (56.38 KB)](/img/orig/DBVT_BIG.D-6e9fc99d.png)

### DBV Technologies Logo large for dark backgrounds Download SVG (7.06 KB)

![DBV Technologies Logo large for dark backgrounds Download SVG (7.06 KB)](/img/orig/DBVT_BIG.D-20daab8d.svg)

## DBV Technologies Logo icon format for dark backgrounds

### DBV Technologies Logo icon format for dark backgrounds Download PNG (34.42 KB)

![DBV Technologies Logo icon format for dark backgrounds Download PNG (34.42 KB)](/img/orig/DBVT.D-77f9e3a1.png)

### DBV Technologies Logo icon format for dark backgrounds Download SVG (1.41 KB)

![DBV Technologies Logo icon format for dark backgrounds Download SVG (1.41 KB)](/img/orig/DBVT.D-2a43bd31.svg)

## About DBV Technologies

DBV Technologies S.A., a clinical-stage biopharmaceutical company, engages in the research and development of epicutaneous immunotherapy products. Its lead product candidate is Viaskin Peanut, an immunotherapy product, which has completed Phase III clinical trial for the treatment of peanut allergies in 4 to 11 years of age children, adolescents, and adults. The milk-induced company is also developing Viaskin Milk that is in Phase I/II clinical trial for the treatment of Immunoglobulin E (IgE) mediated cow's milk protein allergy (CMPA); Viaskin Egg, a pre-clinical stage product for the treatment of hen's egg allergy; and booster vaccine for Bordetella pertussis. Its other earlier stage research programs include a vaccine for the respiratory syncytial virus, as well as treatments for Crohn's disease, celiac disease, and type I diabetes. The company has a collaboration with NestlÃ© Health Science to develop MAG1C, a ready-to-use atopy patch test for the diagnosis of non-IgE mediated CMPA in infants and toddlers. DBV Technologies S.A. was incorporated in 2002 and is headquartered in Montrouge, France.

1. Website domain: dbv-technologies.com
2. Employees: 85
3. Marketcap: $0.31 Billion USD


## Categories
- [x] ðŸ‡«ðŸ‡· France
- [x] ðŸ’Š Pharmaceuticals
- [x] ðŸ§¬ Biotech
